Susan Benton - 11 Jun 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Amy Rabourn, by Power of Attorney
Issuer symbol
OCUP
Transactions as of
11 Jun 2024
Transactions value $
$0
Form type
4
Filing time
13 Jun 2024, 17:25:33 UTC
Previous filing
03 Jan 2024
Next filing
02 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +41,143 +41.6% $0.000000 140,023 11 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (Right to Buy) Award $0 +35,181 $0.000000 35,181 11 Jun 2024 Common Stock 35,181 $1.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
F2 The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney